INTS INTENSITY THERAPEUTICS, INC.
Nasdaq · SEC CIK 1567264 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 33 since 2023-07-21, latest 2026-07-20 16:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wesolowski John M | Principal Accounting Off | — | — |
| Talamo Joseph | CFO | — | — |
| BENDER LEWIS H | Pres, CEO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:09 | 2026-06-30 | INTS | Wesolowski John M | Principal Accounting Off | A - Grant | $3.48 | +3,688 | 7,102 | +108% | +$12.9K | |
| 2026-07-01 16:08 | 2026-06-30 | INTS | Talamo Joseph | CFO | A - Grant | $3.48 | +1,093 | 2,239 | +95% | +$3,809 | |
| 2026-03-30 | 2026-03-26 | INTS | BENDER LEWIS H | Pres, CEO, Dir | A - Grant | $6.11 | +37.7K | 118.5K | +47% | +$230.6K | |
| 2026-01-05 | 2025-12-31 | INTS | Wesolowski John M | Principal Accounting Off | A - Grant | $0.26 | +8,918 | 85.4K | +12% | +$2,319 | |
| 2026-01-05 | 2025-12-31 | INTS | Talamo Joseph | CFO | A - Grant | $0.26 | +14.5K | 28.7K | +102% | +$3,765 | |
| 2025-07-02 | 2025-06-30 | INTS | Talamo Joseph | CFO | A - Grant | $0.26 | +14.2K | 14.2K | New | +$3,687 | |
| 2025-07-02 | 2025-06-30 | INTS | Wesolowski John M | Principal Accounting Off | A - Grant | $0.26 | +69.7K | 76.4K | +1,042% | +$18.1K | |
| D | 2024-06-07 | 2024-06-05 | INTS | Wesolowski John M | Principal Accounting Off | M - OptEx | $4.00 | +1,000 | 6,691 | +18% | +$4,000 |
Purchase Sale Sale after option exercise All abbreviations